Skip to main content
Clinical Trials/ITMCTR2000003094
ITMCTR2000003094
Not yet recruiting
未知

A randomized controlled clinical study: clinical efficacy observation and safety evaluation of acupuncture in the treatment of cancer related insomnia

Yueyang Hospital of integrated traditional Chinese and Western Medicine Affiliated to Shanghai University of traditional Chinese Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Yueyang Hospital of integrated traditional Chinese and Western Medicine Affiliated to Shanghai University of traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Yueyang Hospital of integrated traditional Chinese and Western Medicine Affiliated to Shanghai University of traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who has been diagnosed malignant tumors by histopathology or cytology;
  • 2\. Patients with the insomnia related to cancer treatment or cancer itself has lasted for at least 2 months, meeting the diagnostic criteria for insomnia ;
  • 3\. With total insomnia severity index (ISI) score \>\= 10 points or Pittsburgh sleep Therapeutic Index (PSQI)\> 5 points;
  • 4\. Patients aged \>\= 45 years and \<\= 74 years, no gender restriction;
  • 5\. Patients who volunteer to participate in the study and sign informed consent;
  • 6\. Patients have clear awareness and ability to judge their symptoms and conditions, and able to cooperate to fill out the scale accurately.

Exclusion Criteria

  • 1\. Patients who have been diagnosed as Major Depression, Anxiety, Panic Disorder, or other mental illness; Caffeine, Alcohol, or Drug Addiction; Hamilton Anxiety and Depression Scale Score \>\= 11;
  • 2\. Cancer pain measured by digital rating scale \>\= 4 points;
  • 3\. Patients with serious cardiovascular, respiratory, digestive or hematopoietic diseases, hemophilia or various bleeding disorders;
  • 4\. Patients using pacemakers or anticoagulants;
  • 5\. Pregnant or lactating women;
  • 6\. Patients who stun or cannot tolerate acupuncture;
  • 7\. Patients with local ulceration or infection in the treatment area
  • 8\. Patients with severe cognitive impairment, difficulty in self judging the severity of symptoms, and mental disorders;
  • 9\. Patients who underwent tumor\-related surgery, chemotherapy or radiotherapy in the past month.

Outcomes

Primary Outcomes

Not specified

Similar Trials